Adeno-associated Virus · What It Is, Transmission, Signs, Symptoms, Diagnosis, and More

Published: Dec 02, 2025
Author: Georgina Tiarks
Editor: Alyssa Haag, MD
Editor: Emily Miao, PharmD
Editor: Kelsey LaFayette, DNP, ARNP, FNP-C
Editor: Arianna Succi, MD
Illustrator: Jessica Reynolds, MS
7-day free trial

Go deeper with Osmosis

Osmosis is a learning platform with videos, questions, and AI tools to help you master topics like this.

4.8 · 12,000+ reviews
Watch quick, visual videos
Practice with Qbank-style questions
Use AI to explain, quiz, and review
Study anytime with the mobile app
Start free trial

No credit card · Cancel anytime

What is adeno-associated virus?

Adeno-associated virus (AAV) is a non-enveloped, single-stranded DNA virus heavily studied for its use in gene therapy. The virus belongs to the Dependoparvovirus genus, a subset of the Parvoviridae family, so named because it relies on other viruses for replication. In fact, AAV replication is dependent on coinfection with helper viruses such as adenovirus, herpes simplex virus type 1 (HSV-1), human cytomegalovirus (CMV), varicella zoster virus (VZV), and human herpesvirus-6 (HHV-6). In the absence of helper viruses, AAV integrates its genome into the host cell, and while most copies are eliminated rapidly, some can persist indefinitely. At least 13 AAV serotypes exist, each with a different tissue tropism - i.e., they exhibit a preference for different cell types and tissues in the body (e.g., skeletal muscle, hepatocyte, lymphocytes).  AAV is non-pathogenic, meaning it does not cause disease in humans, making it a promising tool for gene therapy research.  

Adeno-associated virus was originally discovered as a contaminant of adenovirus cultures. It contains a small amount of DNA enclosed in a protective protein shell. Within the DNA, three AAV genes,  Rep (replication), Cap (capsid), and aap (assembly), provide blueprints for the production and building of structural and replication proteins. The three structural capsid proteins are VP1, VP2, and VP3, while the proteins required for replication are known as Rep40, Rep52, Rep68, and Rep78. 

Learn deeper with Osmosis

Master this topic faster with videos, questions, and AI.

Used by 8M+ healthcare learners.

Start free trial

No credit card · Cancel anytime

How can adeno-associated virus be used in gene therapy?

Further research has shown that the viral genome of AAV can be engineered to transport modified DNA into target cells, making it a valuable tool in gene therapy. In particular, AAV can transport DNA or RNA into cells that are missing a specific gene sequence; this is especially useful for single-gene diseases where a single protein is missing. For example, in Duchenne muscular dystrophy, mutations in the DMD gene cause a deficiency of the dystrophin protein. AAV can be used to transport an exogenous dystrophin gene into cells. Currently, the use of AAV serotype 2 (AAV2) is under study for treatment of ovarian cancer, hemophilia B, inherited blindness, and spinal muscular atrophy. Although AAV gene therapy is promising, more research is needed to ensure there are no long-term adverse effects. 

How is adeno-associated virus transmitted?

AAV can be transmitted through various forms of contact with an infected host. The virus has been isolated from blood, cervical mucus, semen, hepatocytes, amniotic fluid, and epithelial cells. Any direct or indirect contact (e.g., touching infected surfaces) with infected fluid could cause transmission. It is uncertain whether vertical transmission from mother to baby can occur. Even without a helper virus, AAV can bind to a host cell receptor (e.g., heparan sulfate proteoglycan, sialic acid) and transfer its viral genome into the host cell through endocytosis. 

What signs and symptoms does adeno-associated virus infection cause?

AAV infection does not cause any signs or symptoms; however, the virus can persist within the host throughout their lifetime. Between 30 and 85% of the population has antibodies to AAV.  

 However, the effects of AAV infection on the human body are still under investigation. Recent research has found an association between AAV2 coinfection, the HLA-DRB1*04:01 allele (i.e.,  genetic variant linked to immune response) and acute hepatitis in children. Evidence also suggests a link between AAV and reproductive system disorders, specifically an increased rate of miscarriage, and liver cancer. Interestingly, AAV infection has been associated with a lower likelihood of developing cervical carcinoma, suggesting a protective effect. 

How is an adeno-associated virus infection diagnosed and treated?

A polymerase chain reaction (PCR) test is required to detect the AAV viral genome and diagnose AAV infection. Because AAV infection is asymptomatic, no specific treatment has been developed. 

What are the most important facts to know about adeno-associated virus?

Adeno-associated virus (AAV) is a single-stranded DNA virus used in gene therapy research. It is non-pathogenic in humans and can only replicate in the presence of helper viruses.  Therefore, it can be used in gene therapy to carry modified DNA into target cells. AAV can be transmitted through contact with infectious material such as feces, blood products, semen, cervical mucus, and amniotic fluid. Infection is asymptomatic, though associations with conditions including miscarriage, liver cancer, and acute hepatitis are being investigated. It can be diagnosed using a PCR test, and no specific treatment has been developed.  

Key Takeaways

Definition 

Adeno-associated virus (AAV) is a non-enveloped, single-stranded DNA virus heavily studied for its use in gene therapy.   

Virus Characteristics  

- Dependoparvovirus genus 

- Subset of the Parvoviridae family  

- Relies on helper viruses for replication (e.g., HSV-1, CMV, VZV, HHV-6)  

- 13 serotypes with different tissue tropism 

- Genes:  

     - Rep (Replication)  

     - Cap (Capsid 

     - aap (Assembly) 

Gene Therapy 

- Viral genome of AAV can be engineered to transport modified DNA into target cells → gene therapy tool  

- Useful for single-gene diseases where a single protein is missing  

     - E.g., Duchenne muscular dystrophy  

- AAV serotype 2 under study for treatment of:  

     - Ovarian cancer   

     - Hemophilia B 

     - Inherited blindness  

     - Spinal muscular atrophy  

Transmission 

- Direct or indirect contact with infected fluid  

     - Blood, cervical mucus, semen, hepatocytes, amniotic fluid, and epithelial cells 

- Uncertain whether vertical transmission can occur  

- Can transfer viral genome into host cell via endocytosis 

Signs and Symptoms 

- No signs and symptoms  

- Persists within host throughout lifetime (30-85% of the population)  

- Possible associations under investigation:  

     - Acute hepatitis in children with HLA-DRB1*04:01 allele  

     - Reproductive system disorders (miscarriage 

     - Liver cancer  

     - Protective effect for cervical carcinoma  

Diagnosis  

- Polymerase chain reaction (PCR) 

Treatment 

- Asymptomatic → no specific treatment   

Students say Osmosis is 100% worth it

Because Osmosis saves them time. Lowers stress. And actually helps them remember when it counts.

I used Osmosis to prepare for my first medical school licensing exam! Super helpful and interactive for people who may not do great with just pages of text info!

Cecilia Ruiz

Cecilia Ruiz

MD student

Sayan Misra

I have used Osmosis for about four years. Best thing I have ever used for my medical studies.

Sayan Misra

Sayan Misra

Med student

Osmosis videos are superior because they define simple concepts, tell a story with a clear progression, and provide context.

Jay Pate

Jay Pate

Dental student

References


AAV serotypes and AAV Tissue-specific Tropism. GeneMedi. Accessed December 8, 2023. https://www.genemedi.net/i/aav-serotypes-tissue-specific-tropism


Grossman Z, Mendelson E, Brok-Simoni F, et al. Detection of adeno-associated virus type 2 in human peripheral blood cells. Journal of General Virology. 1992;73(4):961-966. doi:10.1099/0022-1317-73-4-961


Ho A, Orton R, Tayler R, et al. Adeno-associated virus 2 infection in children with non-A–E hepatitis. Nature. 2023;617(7961):555-563. doi:10.1038/s41586-023-05948-2


Li C, Samulski RJ. Engineering adeno-associated virus vectors for gene therapy. Nat Rev Genet. 2020;21(4):255-272. doi:10.1038/s41576-019-0205-4


Manini A, Abati E, Nuredini A, Corti S, Comi GP. Adeno-associated virus (AAV)-mediated gene therapy for Duchenne muscular dystrophy: The issue of transgene persistence. Front Neurol. 2022;12:814174. doi:10.3389/fneur.2021.814174


Meyer NL, Chapman MS. Adeno-associated virus (AAV) cell entry: Structural insights. Trends in Microbiology. 2022;30(5):432-451. doi:10.1016/j.tim.2021.09.005


Naso MF, Tomkowicz B, Perry WL, Strohl WR. Adeno-associated virus (AAV) as a vector for gene therapy. BioDrugs. 2017;31(4):317-334. doi:10.1007/s40259-017-0234-5


Sant’Anna TB, Araujo NM. Adeno-associated virus infection and its impact in human health: An overview. Virol J. 2022;19:173. doi:10.1186/s12985-022-01900-4